Author

Fuhui Li

Chinese Academy of Medical Sciences & Peking Union Medical College

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Bing Li· 1 shared Gang Huang· 1 shared Jinqin Liu· 1 shared Lin YangiD· 1 shared Raajit K. RampaliD· 1 shared Songyang Zhao· 1 shared Tiejun Qin· 1 shared Wenbin AniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bing Li

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting CD38 effectively prevents myelofibrosis in myeloproliferative neoplasms

Yiru Yan, Jinqin Liu, Songyang Zhao, Fuhui Li, Lin Yang, Zefeng Xu, Tiejun Qin, Xiaofan Zhu, Wenbin An, Gang Huang, Raajit K. Rampal, Zhijian Xiao, Bing Li

This study shows that targeting CD38 in monocytes prevents myelofibrosis in MPN models and identifies CD38 as a potential biomarker and therapeutic target.

bioRxiv · Mar 2, 2025 · PreprintCancer Biology